{
  "openalex_id": "W4392921401",
  "doi": "https://doi.org/10.5114/reum/183469",
  "title": "COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion",
  "abstract": "As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of severe illness in adults with rheumatic and musculoskeletal diseases (RMDs). Several disease-specific (chronic long-grade inflammation, concomitant immunosuppression) and individual (advanced age, multimorbidity, pregnancy, vaccination status) factors contribute to excess risk in RMD populations. Various post-COVID-19 manifestations are also increasingly reported and appear more commonly than in the general population. At a pathogenetic level, complex interplay involving innate and acquired immune dysregulation, viral persistence, and genetic predisposition shapes a unique susceptibility profile. Moreover, incident cases of SARS-CoV-2 infection as a trigger factor for the development of autoimmune conditions have been reported. Vaccination remains a key preventive strategy, and encouraging active education and awareness will be crucial for rheumatologists in the upcoming years. In patients with RMDs, COVID-19 vaccines' benefits outweigh the risks. Derivation of specialized diagnostic and therapeutic protocols within a comprehensive COVID-19 care plan represents an ideal scenario for healthcare system organization. Vigilance for symptoms of infection and rapid diagnosis are key for introducing antiviral treatment in patients with RMDs in a timely manner. This review provides updated guidance on optimal immunization, diagnosis, and antiviral treatment strategies.",
  "authors": [
    {
      "display_name": "Brygida Kwiatkowska",
      "id": "A5026937868",
      "orcid": "https://orcid.org/0000-0002-9622-1830",
      "institutions": [
        {
          "id": "I4210115237",
          "display_name": "Arthritis and Rheumatism Associates",
          "country_code": "US",
          "type": "other"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Brygida Kwiatkowska"
    },
    {
      "display_name": "Magdalena Krajewska–Włodarczyk",
      "id": "A5089712806",
      "orcid": "https://orcid.org/0000-0002-7857-347X",
      "institutions": [],
      "is_corresponding": true,
      "raw_author_name": "Magdalena Krajewska-Włodarczyk"
    },
    {
      "display_name": "Bogdan Batko",
      "id": "A5041297167",
      "orcid": "https://orcid.org/0000-0003-3999-8093",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Bogdan Batko"
    },
    {
      "display_name": "Maria Maślińska",
      "id": "A5062830143",
      "orcid": "https://orcid.org/0000-0002-2211-0302",
      "institutions": [
        {
          "id": "I4210115237",
          "display_name": "Arthritis and Rheumatism Associates",
          "country_code": "US",
          "type": "other"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Maria Maślińska"
    },
    {
      "display_name": "Marcin Stajszczyk",
      "id": "A5001696899",
      "orcid": "https://orcid.org/0000-0002-3939-7194",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Marcin Stajszczyk"
    },
    {
      "display_name": "Jerzy Świerkot",
      "id": "A5072847615",
      "orcid": "https://orcid.org/0000-0003-3606-173X",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Jerzy Świerkot"
    },
    {
      "display_name": "Piotr Wiland",
      "id": "A5007364793",
      "orcid": "https://orcid.org/0000-0001-9999-0267",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Piotr Wiland"
    },
    {
      "display_name": "Zbigniew Żuber",
      "id": "A5012015082",
      "orcid": "https://orcid.org/0000-0001-9581-0601",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Zbigniew Żuber"
    },
    {
      "display_name": "Krzysztof Tomasiewicz",
      "id": "A5043306295",
      "orcid": "https://orcid.org/0000-0001-7868-2708",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Krzysztof Tomasiewicz"
    }
  ],
  "publication_year": 2024,
  "publication_date": "2024-03-18",
  "type": "article",
  "cited_by_count": 0,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S2755932866",
    "display_name": "Reumatologia/Rheumatology",
    "issn_l": "0034-6233",
    "issn": [
      "0034-6233",
      "2084-9834"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320332"
  },
  "volume": "62",
  "issue": "1",
  "first_page": "4",
  "last_page": "17",
  "open_access": {
    "is_oa": true,
    "oa_status": "diamond",
    "oa_url": "https://reu.termedia.pl/pdf-183469-107102?filename=COVID_19 prophylaxis_.pdf",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.91794866
    },
    {
      "id": "C177713679",
      "display_name": "Intensive care medicine",
      "level": 1,
      "score": 0.65024865
    },
    {
      "id": "C22070199",
      "display_name": "Vaccination",
      "level": 2,
      "score": 0.6329351
    },
    {
      "id": "C2779134260",
      "display_name": "Disease",
      "level": 2,
      "score": 0.5874192
    },
    {
      "id": "C2780252810",
      "display_name": "Immunosuppression",
      "level": 2,
      "score": 0.53173465
    },
    {
      "id": "C203014093",
      "display_name": "Immunology",
      "level": 1,
      "score": 0.50529796
    },
    {
      "id": "C2908647359",
      "display_name": "Population",
      "level": 2,
      "score": 0.4845385
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.13332462
    },
    {
      "id": "C99454951",
      "display_name": "Environmental health",
      "level": 1,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T11616",
      "display_name": "Autoimmune and Inflammatory Disorders Research",
      "score": 0.9996
    },
    {
      "id": "T11078",
      "display_name": "Inflammasome and immune disorders",
      "score": 0.9995
    },
    {
      "id": "T11368",
      "display_name": "Long-Term Effects of COVID-19",
      "score": 0.9992
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.5114/reum/183469",
  "pdf_url": "https://reu.termedia.pl/pdf-183469-107102?filename=COVID_19 prophylaxis_.pdf",
  "retrieved_date": "2025-07-30T14:50:43.484504",
  "source_database": "OpenAlex"
}